Life Science Tools Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Life Science Tools Market, By Technology
7.1. Life Science Tools Market, By Technology Type, 2020-2030
7.1.1. Genomic Technology
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Proteomics Technology
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Cell Biology Technology
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Other Analytical & Sample Preparation Technology
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Lab Supplies & Technologies
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Life Science Tools Market, By Product
8.1. Life Science Tools Market, By Product, 2020-2030
8.1.1. Cell Culture Systems & 3D Cell Culture
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Liquid Chromatography
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Mass Spectrometry
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Flow Cytometry
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Cloning & Genome Engineering
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Microscopy & Electron Microscopy
8.1.6.1. Market Revenue and Forecast (2016-2030)
8.1.7. Next Generation Sequencing
8.1.7.1. Market Revenue and Forecast (2016-2030)
8.1.8. PCR & qPCR
8.1.8.1. Market Revenue and Forecast (2016-2030)
8.1.9. Nucleic Acid Preparation
8.1.9.1. Market Revenue and Forecast (2016-2030)
8.1.10. Nucleic Acid Microarray
8.1.10.1. Market Revenue and Forecast (2016-2030)
8.1.11. Sanger Sequencing
8.1.11.1. Market Revenue and Forecast (2016-2030)
8.1.12. Transfection Devices & Gene Delivery Technologies
8.1.12.1. Market Revenue and Forecast (2016-2030)
8.1.13. NMR
8.1.13.1. Market Revenue and Forecast (2016-2030)
8.1.14. Other Separation Technologies
8.1.14.1. Market Revenue and Forecast (2016-2030)
8.1.15. Other Products & Services
8.1.15.1. Market Revenue and Forecast (2016-2030
Chapter 9. Global Life Science Tools Market, By End-use
9.1. Life Science Tools Market, By End-use, 2020-2030
9.1.1. Government & Academic
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Biopharmaceutical Company
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. HealthCare
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Industry
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Life Science Tools Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.2. Market Revenue and Forecast, By Product (2016-2030)
10.1.3. Market Revenue and Forecast, By End-use (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Product (2016-2030)
10.1.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Product (2016-2030)
10.1.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.2. Market Revenue and Forecast, By Product (2016-2030)
10.2.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Product (2016-2030)
10.2.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Product (2016-2030)
10.2.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Product (2016-2030)
10.2.6.3. Market Revenue and Forecast, By End-use (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Product (2016-2030)
10.2.7.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.2. Market Revenue and Forecast, By Product (2016-2030)
10.3.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Product (2016-2030)
10.3.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Product (2016-2030)
10.3.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Product (2016-2030)
10.3.6.3. Market Revenue and Forecast, By End-use (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Product (2016-2030)
10.3.7.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.2. Market Revenue and Forecast, By Product (2016-2030)
10.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Product (2016-2030)
10.4.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Product (2016-2030)
10.4.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Product (2016-2030)
10.4.6.3. Market Revenue and Forecast, By End-use (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Product (2016-2030)
10.4.7.3. Market Revenue and Forecast, By End-use (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.2. Market Revenue and Forecast, By Product (2016-2030)
10.5.3. Market Revenue and Forecast, By End-use (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Product (2016-2030)
10.5.4.3. Market Revenue and Forecast, By End-use (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Product (2016-2030)
10.5.5.3. Market Revenue and Forecast, By End-use (2016-2030)
Chapter 11. Company Profiles
11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. F. Hoffmann-La Roche AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Illumina, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Thermo Fisher Scientific, Inc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. QIAGEN
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Merck KGaA
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Shimadzu Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Hitachi, Ltd.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Bruker
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Oxford Instruments plc
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Zeiss International
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers